Applied Therapeutics Inc (NASDAQ:APLT)
| 1.21 Delayed Data As of Jan 27 |  +0.07 / +6.14%Today’s Change | 0.50 Today|||52-Week Range 3.25 | +59.21% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $54.3M |
Company Description
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.
Contact Information
Applied Therapeutics, Inc. 545 5th Avenue New York New York 10017 |
Employees
Shareholders
| Other institutional | 8.67% |
| Mutual fund holders | 34.64% |
| Individual stakeholders | 26.60% |
Top Executives
| Shoshana Shendelman | Chairman, President, CEO & Secretary |
| Chids Mahadevan | Senior Vice President-Finance |
| Riccardo Perfetti | Chief Medical Officer |
| Adam Hansard | Chief Commercial Officer |
| Steven Ortega | Chief Accounting Officer |
